We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Eidogen-Sertanty Licenses Target Informatics Platform to NCBI
News

Eidogen-Sertanty Licenses Target Informatics Platform to NCBI

Eidogen-Sertanty Licenses Target Informatics Platform to NCBI
News

Eidogen-Sertanty Licenses Target Informatics Platform to NCBI

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Eidogen-Sertanty Licenses Target Informatics Platform to NCBI"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Eidogen-Sertanty, Inc. has announced that they have licensed their Target Informatics Platform™ (TIP™) to the U.S. National Library of Medicine’s National Center for Biotechnology Information (NCBI), based in Bethesda, MD.

Under the terms of the annual license, scientists at the NCBI will have access to the TIP structural knowledgebase as well as Eidogen-Sertanty’s EVE Comparative Visualizer.

"We’re extremely pleased to be collaborating with the NCBI. They have developed a number of outstanding and widely used informatics platforms over the years, and I’m optimistic that our interaction will lead to new high impact advances," said Derek Debe, Eidogen-Sertanty’s Chief Scientific Officer.

Advertisement